Top 4 Vendors in the Global Surgical Ablation Market from 2017 to 2021: Technavio

Technavio has published a new report on the global surgical ablation market from 2017-2021.

LONDON--()--Technavio has announced the top four leading vendors in their recent global surgical ablation market report. This market research report also lists 21 other prominent vendors that are expected to impact the market during the forecast period.

Competitive vendor landscape

According to the research analysis, the global surgical ablation market is growing at a significant rate, driven by an increase in the older population and technological advances in the treatment of AFib, liver cancer, and tumors. It is expected to witness significant growth in emerging countries such as India and China during the forecast period.

The competition among the key vendors in the market is expected to intensify during the forecast period with the enhancement of product extensions, new product launches, and M&A. Vendors need to use innovative strategies and introduce a broad portfolio to improve their positions in the market. The competitive environment in the market is largely due to the design and manufacturing cost of a product. Local vendors offer products at comparatively lesser cost as compared with key players, which allows customers to choose from a variety of low margin products.

“Customers from developing countries have low awareness of new products and owing to their low purchasing power; they prefer to source products from local vendors as they provide better after-sales support. This obliges global players to phase out their product prices leading to price wars,” says Barath Palada, a lead analyst at Technavio for orthopedics and medical devices research.

AngioDynamics, Boston Scientific, Johnson & Johnson, and Medtronic are the leading vendors in the global surgical ablation market. Vendors focus on conducting evidence-based studies to showcase the performance, efficacy, and long-term cost-effectiveness of their products. These studies are also important in convincing medical professionals to increase their adoption of these procedures. Also, many vendors conduct workshops and training programs to increase awareness about the procedure and improve physician referral for the procedure.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

Technavio market research analysts identify the following key vendors:


AngioDynamics is a medical device company, which develops and manufactures medical, surgical, diagnostic and therapeutic devices for the treatment of vascular diseases, tumors, and other non-coronary conditions. It has a broad range of product portfolio, which is used in MI and image-guided procedures. The surgical ablation products fall under the category of oncology/surgery division, which is sub-categorized as radiofrequency ablation, microwave ablation, and NanoKnife product lines.

Boston Scientific

Boston Scientific engages in the development, manufacture, and distribution of a broad range of products in interventional radiology, interventional cardiology, neuromodulation, peripheral interventions neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology, and gynecology therapy areas. The company offers the various surgical ablation products under the rhythm management segment. It offers a wide range of product lines within radiofrequency application segment.

Johnson & Johnson

Johnson & Johnson operates in three major business segments: medical devices and diagnostics, pharmaceuticals, and consumer products. The company offers a comprehensive range of surgical ablation devices that are used in bariatric, cardiovascular, colorectal, general, gynecologic, thoracic, breast, trauma, and acute surgeries. The company sells its ablation devices under the medical devices segment.


Medtronic offers pharmaceuticals, medical technology, services, and solutions. The company has a broad product portfolio for various therapy areas and showed growth in four groups, namely, cardiac and vascular, MI therapies, restorative therapies, and diabetes. Its surgical ablation products fall in the cardiac and vascular group which is subdivided as coronary and structural heart, cardiac rhythm and heart failure and aortic and peripheral vascular.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Browse Related Reports:

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Technavio has announced the top four leading vendors in their recent global surgical ablation market report from 2017-2021.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770